Oral melphalan, prednisone,thalidomide versus oral melphalan, prednisone in elderly newly diagnosed myeloma patients

被引：0
|
作者：
Palumbo, A.
Bringhen, S.
Caravita, T.
Falcone, A.
Callea, V.
Cangialosi, C.
Grasso, M.
Galli, M.
Rossini, F.
Catalano, L.
Montanaro, M.
De Stefano, V.
Magarotto, V.
Avonto, I.
Musto, P.
Liberati, A. M.
Cavo, M.
Boccadoro, M.
机构：
[1] Az Osp S Giovanni Battista, Turin, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[4] Osped Riuniti Reggio Calabria, Reggio Di Calabria, Italy
[5] Az Osp Cervello, Palermo, Italy
[6] Az Osp S Croce & Carle, Cuneo, Italy
[7] Osped San Gerardo, Monza, Italy
[8] Univ Naples Federico II, Naples, Italy
[9] Osped S Anna, Ronciglione, Italy
[10] Univ Cattolica, Rome, Italy
[11] Ctr Riferimento Oncol Basilicata, Rionero In Vulture, Italy
[12] Monteluce Policlin, Perugia, Italy
[13] Univ Bologna, Ist Seragnoli, Bologna, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0401
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [41] Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Overall Survival in Alcyone
    Mateos, Maria-Victoria
    Cavo, Michele
    Blade, Joan
    Dimopoulos, Meletios A.
    Suzuki, Kenshi
    Jakubowiak, Andrzej
    Knop, Stefan
    Doyen, Chantal
    Lucio, Paulo
    Nagy, Zsolt
    Pour, Ludek
    Cook, Mark
    Grosicki, Sebastian
    Crepaldi, Andre H.
    Liberati, Anna Marina
    Campbell, Philip
    Shelekhova, Tatiana
    Yoon, Sung-Soo
    Iosava, Genadi
    Fujisaki, Tomoaki
    Garg, Mamta
    Krevvata, Maria
    Wang, Jianping
    Kudva, Anupa
    Ukropec, Jon
    Wroblewski, Susan
    Kobos, Rachel
    San-Miguel, Jesus
    BLOOD, 2019, 134
  • [42] BORTEZOMIB-MELPHALAN-PREDNISONE VERSUS MP AS INITIAL TREATMENT FOR VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Kim, M. K.
    Kim, K.
    Yoon, D. H.
    Suh, C.
    Moon, J. H.
    Lee, Y. J.
    Lee, J. H.
    Jung, S. -H.
    Kim, H. J.
    Bae, S. H.
    Kim, J. S.
    Lee, J. -O.
    Eom, H. S.
    Lee, W. -S.
    Kang, H. J.
    Mun, Y. -C.
    Do, Y. R.
    Hyun, M. S.
    HAEMATOLOGICA, 2017, 102 : 793 - 793
  • [43] Low dose thalidomide and dexamethasone are as effective as oral melphalan and prednisone in refractory and relapsed myeloma patients.
    Palumbo, A
    Giaccone, L
    Bringhen, S
    Cavallo, F
    Falco, P
    Rus, C
    Bertola, A
    Pileri, A
    Boccadoro, M
    BLOOD, 2001, 98 (11) : 162A - 162A
  • [44] Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis (vol 4, pg 689, 2011)
    Kapoor, P.
    Rajkumar, S. V.
    Dispenzieri, A.
    Gertz, M. A.
    Lacy, M. Q.
    Dingli, D.
    Mikhael, J. R.
    Roy, V.
    Kyle, R. A.
    Greipp, P. R.
    Kumar, S.
    Mandrekar, S. J.
    LEUKEMIA, 2011, 25 (09) : 1523 - 1524
  • [45] Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma
    Palumbo, Antonio
    Ambrosini, Maria Teresa
    Benevolo, Giulia
    Pregno, Patrizia
    Pescosta, Norbert
    Callea, Vincenzo
    Cangialosi, Clotilde
    Caravita, Tommaso
    Morabito, Fortunato
    Musto, Pellegrino
    Bringhen, Sara
    Falco, Patrizia
    Avonto, Ilaria
    Cavallo, Federica
    Boccadoro, Mario
    BLOOD, 2007, 109 (07) : 2767 - 2772
  • [46] Efficacy and safety of Daratumumab, Bortezomib, Melphalan, and Prednisone (D-VMP) versus Bortezomib, Melphalan, and Prednisone (VMP) in Chinese patients with newly diagnosed Multiple Myeloma: OCTANS
    Fu, Weijun
    Huang, Honghui
    Li, Wei
    An, Gang
    Cai, Zhen
    Jin, Jie
    Wang, Yafei
    Chim, Chor Sang
    Qi, Ming
    Wang, Jianping
    Song, Yang
    Jia, Bin
    Yang, Xue
    Liu, Wenyu
    Li, Yunan
    Zhang, Renyi
    Hou, Jian
    Wang, Jianxiang
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S125 - S125
  • [47] Randomized comparison of dexamethasone combined with melphalan versus melphalan with prednisone in the treatment of elderly patients with multiple myeloma
    Hernández, JM
    García-Sanz, R
    Golvano, E
    Bladé, J
    Fernandez-Calvo, J
    Trujillo, J
    Soler, JA
    Gardella, S
    Carbonell, F
    Mateo, G
    San Miguel, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (02) : 159 - 164
  • [48] Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial
    Mateos, Maria-Victoria
    Oriol, Albert
    Martinez-Lopez, Joaquin
    Gutierrez, Norma
    Teruel, Ana-Isabel
    de Paz, Raquel
    Garcia-Larana, Jose
    Bengoechea, Enrique
    Martin, Alejandro
    Diaz Mediavilla, Joaquin
    Palomera, Luis
    de Arriba, Felipe
    Gonzalez, Yolanda
    Hernandez, Jose-Mariano
    Sureda, Ana
    Bello, Jose-Luis
    Bargay, Joan
    Penalver, Francisco-Javier
    Ribera, Jose-Maria
    Martin-Mateos, Maria-Luisa
    Garcia-Sanz, Ramon
    Cibeira, Maria-Teresa
    Martin Ramos, Maria-Luisa
    Vidriales, Maria-Belen
    Paiva, Bruno
    Montalban, Maria-Angeles
    Lahuerta, Juan-Jose
    Blade, Joan
    San Miguel, Jesus-Fernando
    LANCET ONCOLOGY, 2010, 11 (10): : 934 - 941
  • [49] Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide
    Palumbo, A.
    Rus, C.
    Zeldis, J. B.
    Rodeghiero, F.
    Boccadoro, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (08) : 1842 - 1845
  • [50] Bortezomib-Melphalan-Prednisone (VMP) Versus MP as Initial Treatment for Very Elderly Patients With Newly Diagnosed Multiple Myeloma
    Kim, Min Kyoung
    Kim, Kihyun
    Yoon, Do Hyun
    Suh, Cheolwon
    Moon, Joon Ho
    Lee, Yoo Jin
    Lee, Jae Hoon
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Hyo Jung
    Bae, Sung Hwa
    Kim, Jin Seok
    Lee, Jeong-Ok
    Eom, Hyeon Seok
    Lee, Won-Sik
    Kang, Hye Jin
    Mun, Yeung-Chul
    Do, Young Rok
    Hyun, Myung Soo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E70 - E70
12345